Tech Company M&A Transactions
Lumena Pharmaceuticals Acquisition
Based in San Diego, Lumena Pharmaceuticals was acquired by Shire Pharmaceuticals. Deal value was $260 million.
Transaction Overview
Company Name
Acquired By
Announced On
5/12/2014
Transaction Type
M&A
Amount
$260,000,000
M&A Terms
Shire will acquire Lumena Pharmaceuticals for an upfront payment of $260 million in cash, plus a payment for net cash at closing, and near-term contingent milestone payments related to ongoing clinical trials.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
12531 High Bluff Drive 110
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
Lumena Pharmaceuticals is focused on advancing treatments in metabolic diseases that have high unmet clinical needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Grey
Chief Financial Officer
Alana McNulty
Chief Medical Officer
Alejandro Dorenbaum
VP - Operations
Ciara Kennedy
VP - R & D
Bradley Keller
Browse more venture capital transactions:
Prev: 5/12/2014: UrbanSitter venture capital transaction
Next: 5/12/2014: Akros Silicon venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs